IBM’s Mainframe Rocket and Quantum Billions Clash With a Stalled Consulting Engine
Published on 07/05/2026 at 03:03 | Redaktion boerse-global.de
IBM’s latest quarterly report revealed a company running at two distinct speeds. Overall revenue climbed 6%, driven by a software segment that expanded 8% and an infrastructure unit that surged 12%. At the heart of that infrastructure boom sits the mainframe “Z” line, where sales shot up by nearly half. Yet the consulting arm, once a reliable profit engine, managed only 1% growth — barely a crawl.
The contrasts don’t stop there. While the mainframe hums, IBM is placing an enormous bet on tomorrow’s technology. Over the next five years, the company plans to spend more than $10 billion on quantum computing, targeting the first fully scaled quantum machine by 2029. Even the U.S. government has thrown its weight behind the effort, funding a domestic quantum fabrication facility — an unusually direct endorsement of an old-line tech giant.
That long-range wager has helped inject startup-like volatility into a stock that was once a dividend stalwart. Holding IBM shares over the past twelve months delivered a total return of just 1.27%, but the path was anything but smooth. After dipping to €181 in the spring, the stock rocketed to €293 before retreating. On Friday, it closed at €251.50, a weekly gain of nearly 6%, and sits comfortably above its 200-day moving average.
Should investors sell immediately? Or is it worth buying IBM?
The options market is pricing in even more turbulence. Traders see a 68% probability that the stock will trade anywhere between $180 and $439 over the next year — a staggering range that underscores the tension between IBM’s operational momentum and management’s cautious full-year guidance of roughly 5% currency-adjusted revenue growth.
The biggest source of that caution appears to be the consulting division. Generative AI threatens to automate the modernization of legacy programming languages like COBOL, directly undercutting the lucrative consulting work that has generated steady revenue for decades. This fear triggered a sharp single-day sell-off recently, as investors woke up to the double-edged nature of AI: it fills software order books but could hollow out the consulting practice.
Despite the jitters, the technical picture remains intact. The share price has held 13% above its 50-day moving average, and the relative strength index sits at a neutral 62, suggesting no overbought pressure. The near-term trend points higher, yet analysts are notably skeptical. The average price target of roughly €257 leaves little room for upside, creating a collective wait-and-see stance.
All eyes are now on July 22, when IBM reports second-quarter earnings. Management will need to show that the much-hyped AI pipeline is translating into real revenue, not just promises. Investors are demanding proof that the company can simultaneously defend its consulting fortress while pouring billions into a quantum future. Until then, IBM remains caught in its own contradiction — a legacy giant trying to reinvent itself without losing its footing in the present.
Ad
IBM Stock: New Analysis - 5 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
